Literature DB >> 6104265

Immune-complex inhibition of lymphocyte Fc gamma-receptors in primary biliary cirrhosis: a possible immunomodulatory mechanism.

G P Sandilands, I Galbraith, F M Reid, P R Mills, R N MacSween.   

Abstract

20 patients with primary biliary cirrhosis (PBC) had circulating IgG-containing immune complexes. These complexes bind to lymphocyte Fc gamma-receptors in vitro; there was also evidence for in-vivo binding. Such in-vivo binding to T and K lymphocytes may exert an immunomodulatory effect on these cells, and may also explain some of the serological and cellular abnormalities in PBC.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104265     DOI: 10.1016/s0140-6736(80)92890-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis.

Authors:  L Zhang; A P Weetman; D R Jayne; I Turner; S J Yeaman; M F Bassendine; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.

Authors:  R M Hoffmann; G R Pape; U Spengler; E P Rieber; J Eisenburg; J Döhrmann; G Paumgartner; G Riethmüller
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  Alterations in T lymphocytes and T-lymphocyte subpopulations in patients with syphilis.

Authors:  J R Jensen; E From
Journal:  Br J Vener Dis       Date:  1982-02

4.  Evaluation of serum rosette inhibitory factors in chronic liver disease.

Authors:  D Zauli; F B Bianchi; M Fusconi; C Crespi; E Pisi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Circulating immune complexes in primary biliary cirrhosis: interactions with lymphoid cells.

Authors:  J L Dienstag; A M Savarese; R B Cohen; A K Bhan
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.